Raub Brock Capital Management LP Upped Factset Research Systems (FDS) Holding By $1.43 Million; 1 Analysts Bullish IntelliPharmaCeutics International Inc. (IPCI)

February 20, 2018 - By Lawrence Diaz

Among 2 analysts covering Intellipharmaceutics Intl (NASDAQ:IPCI), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Intellipharmaceutics Intl had 7 analyst reports since December 31, 2015 according to SRatingsIntel. The stock of IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) has “Buy” rating given on Monday, February 12 by H.C. Wainwright. The stock of IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) has “Buy” rating given on Friday, June 30 by Maxim Group. The rating was maintained by Maxim Group on Tuesday, June 6 with “Buy”. On Thursday, December 31 the stock rating was maintained by Maxim Group with “Buy”. The firm earned “Buy” rating on Friday, July 21 by Maxim Group. The stock has “Hold” rating by Maxim Group on Friday, February 16. See IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) latest ratings:

16/02/2018 Broker: Maxim Group Rating: Hold Downgrade
12/02/2018 Broker: H.C. Wainwright Rating: Buy New Target: $2.5 Maintain
19/01/2018 Broker: H.C. Wainwright Rating: Buy New Target: $2.5 Initiates Coverage On

Raub Brock Capital Management Lp increased Factset Research Systems (FDS) stake by 9.25% reported in 2017Q3 SEC filing. Raub Brock Capital Management Lp acquired 7,965 shares as Factset Research Systems (FDS)’s stock declined 11.25%. The Raub Brock Capital Management Lp holds 94,088 shares with $16.95 million value, up from 86,123 last quarter. Factset Research Systems now has $7.89 billion valuation. The stock increased 0.18% or $0.37 during the last trading session, reaching $202.18. About 301,119 shares traded. FactSet Research Systems Inc. (NYSE:FDS) has risen 5.61% since February 20, 2017 and is uptrending. It has underperformed by 11.09% the S&P500.

Among 19 analysts covering FactSet Research Systems Inc. (NYSE:FDS), 2 have Buy rating, 3 Sell and 14 Hold. Therefore 11% are positive. FactSet Research Systems Inc. had 37 analyst reports since September 22, 2015 according to SRatingsIntel. Stifel Nicolaus maintained it with “Hold” rating and $169.0 target in Tuesday, September 26 report. The firm has “Outperform” rating given on Monday, October 23 by Credit Suisse. The firm earned “Outperform” rating on Wednesday, September 27 by Credit Suisse. On Wednesday, January 31 the stock rating was maintained by Morgan Stanley with “Equal-Weight”. The rating was maintained by Barclays Capital with “Equal-Weight” on Wednesday, March 16. The firm earned “Buy” rating on Tuesday, September 22 by Jefferies. The firm has “Equal Weight” rating given on Wednesday, September 23 by Barclays Capital. The rating was maintained by UBS with “Sell” on Wednesday, December 20. The rating was maintained by Morgan Stanley on Monday, October 23 with “Equal-Weight”. As per Wednesday, September 27, the company rating was maintained by Barclays Capital.

Since September 29, 2017, it had 0 buys, and 7 sales for $13.64 million activity. MCGONIGLE JAMES J also sold $229,989 worth of FactSet Research Systems Inc. (NYSE:FDS) shares. Another trade for 9,458 shares valued at $1.71 million was sold by Hale Mark J.. Another trade for 2,419 shares valued at $465,174 was sold by BILLEADEAU SCOTT A. McNulty Matthew J sold 1,000 shares worth $198,000. Snow Frederick Philip had sold 7,334 shares worth $1.33M on Monday, October 2.

Investors sentiment decreased to 1.08 in Q3 2017. Its down 0.01, from 1.09 in 2017Q2. It dived, as 29 investors sold FDS shares while 112 reduced holdings. 40 funds opened positions while 112 raised stakes. 36.28 million shares or 0.35% less from 36.41 million shares in 2017Q2 were reported. Regions reported 9,493 shares stake. Page Arthur B, a Massachusetts-based fund reported 2,540 shares. Moreover, Sei Invests has 0% invested in FactSet Research Systems Inc. (NYSE:FDS) for 4,619 shares. Proshare Advisors Limited Com invested in 64,163 shares. Citadel Advsrs Ltd Llc holds 325,183 shares or 0.04% of its portfolio. Raub Brock Capital Mngmt Ltd Partnership owns 94,088 shares. Voya Investment Mgmt Ltd Limited Liability Company has 0.01% invested in FactSet Research Systems Inc. (NYSE:FDS) for 19,432 shares. Moreover, Tiaa Cref Inv Management Lc has 0.02% invested in FactSet Research Systems Inc. (NYSE:FDS) for 141,599 shares. 113,807 were reported by Invesco. Papp L Roy And Assocs accumulated 31,876 shares or 1.24% of the stock. Mason Street Advsr Lc has invested 0.09% of its portfolio in FactSet Research Systems Inc. (NYSE:FDS). Rafferty Asset Mngmt Limited Liability Company reported 0.03% in FactSet Research Systems Inc. (NYSE:FDS). Richard Bernstein Advsrs Limited Liability, a New York-based fund reported 17,773 shares. Gsa Capital Ltd Liability Partnership stated it has 1,376 shares. Finemark Bank & Tru holds 0.03% of its portfolio in FactSet Research Systems Inc. (NYSE:FDS) for 2,140 shares.

The stock decreased 9.32% or $0.0718 during the last trading session, reaching $0.6982. About 966,123 shares traded or 148.98% up from the average. IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) has risen 16.57% since February 20, 2017 and is uptrending. It has underperformed by 0.13% the S&P500.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>